| Name | (3R)-3-(4-chlorophenyl)-4-[[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino]butanoic acid |
|---|---|
| Synonyms |
XP19986
(3R)-3-(4-Chlorophenyl)-4-({[(1S)-1-(isobutyryloxy)-2-methylpropoxy]carbonyl}amino)butanoic acid UNII-W89H91R7VX Arbaclofen placarbil Benzenepropanoic acid, 4-chloro-β-[[[[(1S)-2-methyl-1-(2-methyl-1-oxopropoxy)propoxy]carbonyl]amino]methyl]-, (βR)- |
| Description | Arbaclofen placarbil is a novel transported prodrug of the active R-isomer of baclofen. Baclofen is a racemic GABAB receptor agonist |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 545.1±50.0 °C at 760 mmHg |
| Molecular Formula | C19H26ClNO6 |
| Molecular Weight | 399.866 |
| Flash Point | 283.5±30.1 °C |
| Exact Mass | 399.144867 |
| PSA | 105.42000 |
| LogP | 4.39 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.523 |
|
~%
847353-30-4 |
| Literature: XENOPORT, INC.; RAILLARD, Stephen P; MANTHATI, Suresh K; JOSHI, Sudhir Patent: WO2013/23155 A1, 2013 ; |